Medicis Seeks To Block Generic Loprox Shampoo

Law360, New York (July 21, 2011, 3:47 PM EDT) -- Medicis Pharmaceutical Corp. launched three lawsuits in New York on Tuesday in an effort to block competitors from producing generic versions of its seborrheic dermatitis treatment Loprox Shampoo.

The specialty pharmaceutical company filed complaints against Nycomed US Inc., Perrigo Co. Inc. and Taro Pharmaceuticals USA Inc. claiming the defendants violated its patent for the prescription shampoo.

The lawsuits allege the three have marketed generic products that infringe Medicis' patent, U.S. Patent Number 7,981,909, titled “Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis.”

Seborrheic dermatitis is...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Medicis Pharmaceutical Corporation v. Nycomed U.S., Inc


Case Number

1:11-cv-04962

Court

New York Southern

Nature of Suit

Patent

Judge

Alison J. Nathan

Date Filed

July 18, 2011


Case Title

Medicis Pharmaceutical Corporation v. Perrigo Company, Inc.


Case Number

1:11-cv-04963

Court

New York Southern

Nature of Suit

Patent

Judge

Alison J. Nathan

Date Filed

July 18, 2011


Case Title

Medicis Pharmaceutical Corporation v. Taro Pharmaceuticals U.S.A., Inc. et al


Case Number

1:11-cv-04965

Court

New York Southern

Nature of Suit

Patent

Judge

Alison J. Nathan

Date Filed

July 19, 2011

Law Firms

Companies

Government Agencies

Patents

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.